Pfizer CEO expects more people will need COVID pills in futu

Pfizer CEO Albert Bourla on Tuesday, February 8, predicted that the company will manufacture 120 million doses of the Wuhan coronavirus (COVID-19) pill Paxlovid in 2022 – 30 million in the first two quarters and 90 million in the last two quarters of the year. The antiviral drug received emergency use authorization from the Food and Drug […]

Related Keywords

India , Wuhan , Hubei , China , Omega Pharma , Robert Langer , Mao Huinhoa , Timothy Springer , Pankaj Patel , Sarat Sethi , Cyrus Poonawalla , Stephane Bancel , Wu Guanjiang , Andreas Struengmann , Juan Lopez Belmonte , Qiu Dongxu , Zhu Tao , Jiang Rensheng , Noubar Afeyan , Cansino Biologics , Ugur Sahin , Pfizer , Arena Pharmaceuticals Inc , Drug Administration , Serum Institute Of India , Reuters , Wall Street Journal , Arena Pharmaceuticals , Big Pharma , Chairman Noubar Afeyan , Chief Scientific Officer Zhu Tao , Senior Vice President , Senior Vice President Mao Huinhoa , Zhifei Biological Chairman Jiang Rensheng , Serum Institute , Tse Ping , Zhifei Biological , Cadila Healthcare , Patrick Soon Shiong ,